Post-ERCP Pancreatitis Prevention by Stent Insertion

Study to Reduce Incidence of Post-ERCP Pancreatitis by Stent Insertion in the Main Pancreatic Duct After Unintended Cannulation of the Main Pancreatic Duct

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01673763

Acronym

PEPSI

Enrollment

169

Registered

2012-08-28

Start date

2010-07-31

Completion date

2017-08-31

Last updated

2017-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-ERCP Acute Pancreatitis

Keywords

ERCP, endoscopy, pancreatitis

Brief summary

The presented study is designed to analyze the efficacy of pancreatic stent insertion in patients undergoing ERCP with accidental cannulation of the pancreatic duct.

Interventions

DEVICEStent insertion into the main pancreatic duct

Stent insertion into the main pancreatic duct

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* all patients undergoing ERCP with unintended cannulation or opifiacation of main pancreatic duct * age \> 17 years * signed informed consent

Exclusion criteria

* intention to intervene main pancreatic duct * age \< 18 years * pregnancy * absent of signed informed consent

Design outcomes

Primary

Measure	Time frame
Incidence of post-ERCP pancreatitis	up to 1 week

Countries

Belgium, Germany, Latvia, Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026